CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Learn ways to generate income quickly with effective strategies. These tips will help you boost your earnings in no time.
21,313 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Cardano's governance changes are triggering uncertainty. This article explains why cardano's founder predicts hard ti...
Investors are focused on a pivotal point in the Iran deal: how verification and enforcement are managed as sanctions ...
U.S. Q1 GDP was revised higher to a 2.1% annualized pace, topping prior estimates. The gain sparks relief in markets ...
A Louisiana tax preparer allegedly used fabricated W-2 withholding data to boost client refunds. This in-depth guide ...
Ally Bank Savings remains a popular online choice for those who want a straightforward, fee-free high-yield option. T...
When top stars clash over spotlight, everyday money lessons emerge. Learn how to translate big-budget show dynamics i...
Discover two AI stocks that Wall Street analysts believe could move significantly higher. Learn what makes them stron...
When a TV showdown becomes a real-world rental, fans race to lock in a stay and lenders notice. This article breaks d...
A new institutional stake in Telephone and Data Systems has sparked questions about its implications. This guide expl...
Oil prices have spiked more than 25% since the conflict began, but oil stocks have barely moved. This guide explains ...
A regional war has unsettled energy markets, prompting a global push toward remote work. Observers say iran reviving ...